The enduring somatic threat (EST) model of posttraumatic stress disorder (PTSD) due to life-threatening medical events suggests that PTSD-like symptoms represent patients' sensitization to cues of ongoing threat in the body. In this article, we review research on the prevalence and consequences of such reactions in cardiovascular disease patients, discuss early tests of the EST model, and then report a new test of the EST model in 143 patients enrolled during their first acute coronary syndrome (ACS; i.e., non-ST elevation myocardial infarction or unstable anginacolloquially, "heart attack"). Invasive coronary revascularization procedures are commonly used to reduce secondary ACS risk and may reduce patients' EST, as revascularized patients often report being "cured." We assessed ACS patients' initial threat perceptions during emergency department (ED) evaluation and followed them for 1 month for PTSD symptoms (specific for ACS, by telephone). We compared PTSD symptoms in participants who were revascularized (n ϭ 65), catheterized but not revascularized (n ϭ 35), and medically managed (n ϭ 43). PTSD symptoms were lower for revascularized versus medically managed participants (B ϭ Ϫ5.32, 95% confidence interval [Ϫ9.77, Ϫ0.87]), t(98.19) ϭ Ϫ2.37, p ϭ .020. In a multiple regression model adjusted for clinical and psychosocial covariates, the interaction of threat perception in the ED and ACS management group was significant (greater ED threat predicted greater 1-month PTSD symptoms only in medically managed participants). These findings offer further support for the EST model and suggest that psychological interventions to preempt patients' development of EST should be considered in the hospital.
Many patients experience sudden, life-threatening medical events as traumatic. One in eight patients screens positive for posttraumatic stress disorder (PTSD) after an acute coronary syndrome (ACS; i.e., non-ST elevation myocardial infarction [NSTEMI] or unstable angina [UA] pectoris; colloquially, "heart attack"), as do one in four after stroke or transient ischemic attack (TIA). The best estimate to date of the proportion of all PTSD in the United States that is due to medical events was recently offered by Sommer, Mota, Edmondson, and El-Gabalawy (2018) , who found that nearly 7% of PTSD cases in a nationally representative study were illness-induced.
Although the Diagnostic and Statistical Manual of Mental Disorders (5th ed.; American Psychiatric Association, 2013) suggests that PTSD-like reactions to acute life-threatening medical events should likely be categorized as adjustment disorder, the reasoning behind that suggestion is unclear. Although adjustment disorder, like PTSD, involves psychological distress and significant functional impairment (American Psychiatric Association, 2013), little empirical evidence exists for, or against, categorizing cardiac patients' symptoms as PTSD, adjustment disorder, or some other diagnosis. However, whatever the appropriate diagnostic term, the size of the population affected and the apparent consequences of PTSD-like reactions for health behaviors and secondary cardiovascular risk after acute cardiovascular events warrant greater engagement from psychology researchers and clinicians. This article will review existing evidence concerning the nature and consequences of the set of symptoms currently termed PTSD due to acute cardiovascular events. In it, we use the enduring somatic threat (EST) model (Edmondson, 2014) as a framework for understanding unique and shared characteristics of PTSD due to life-threatening medical events versus PTSD due to traumas that originate outside the body.
Further, we report new evidence concerning the association of different acute cardiovascular disease (CVD) interventions with subsequent psychological adjustment in a cohort study of ACS patients. To conclude, we discuss the implications of our findings for understanding the role of EST perceptions in the development and maintenance of PTSD-like symptoms after ACS, and for clinical researchers designing interventions to offset PTSD risk in CVD patients.
Acute Life-Threatening Cardiovascular Events
CVD is the leading cause of death and disability in developed nations. In the present article, we focus on two types of CVD: ACS and stroke/TIA. ACS is a generic term for acute cardiac events caused by reduced blood flow to the heart (i.e., ischemia). Some ACS events result in permanent cardiac tissue death and others do not, but most signal systemic hardening of the arteries, vulnerable arterial plaques, and risk for subsequent ischemic events that may require surgical intervention, medical management, and/or lifestyle changes. More than 1 million patients are hospitalized annually for ACS in the United States alone (Benjamin et al., 2017; Bertoni, Bonds, Thom, Chen, & Goff, 2005) .
Stroke is the leading cause of serious disability and the fifth leading cause of death in the United States. The 800,000 new strokes annually (Mozaffarian et al., 2016) are anticipated to increase dramatically by 2030, as the population ages with worse cardiovascular risk than prior generations (Ovbiagele et al., 2013) . The vast majority of strokes are ischemic (loss of blood flow to the brain), and 15% of all ischemic strokes are preceded by a TIA (Benjamin et al., 2017) . TIA is a transient episode of neurologic dysfunction that is caused by ischemia but does not result in tissue death, so stroke symptoms resolve within 24 hr. The incidence of TIA in the United States is more than 240,000 per year (Edlow, Kim, Pelletier, & Camargo, 2006) , and acute clinical management of the two diagnoses is the same (henceforth, we use the abbreviation TIAMS to refer to TIA/minor stroke; Johnston et al., 2006) .
The Patient Experience of an Acute CVD Event
Acute cardiovascular events such as ACS and TIAMS can be terrifying. Most cause significant chest and/or arm pain, shortness of breath, and substantial distress. Indeed, in our recent study of patients evaluated for ACS in a large, urban emergency department, greater than 95% reported that they had experienced chest pain during the ACS . The acute psychological response during emergency department (ED) evaluation varied across patients, but 15% were at least "moderately" afraid that they would die, and many more reported feeling vulnerable, and not in control. More than 40% reported that the cardiac event would have a major impact on their lives.
TIAMSs result in sudden and often progressive loss of bodily control and cognitive function. Stroke survivors interviewed within 72 hr of stroke onset describe the terror of feeling an affected arm or leg became weaker to the point of paralysis. Fear of recurrence is common and contributes to patients' profound feelings of loss of control over the self and future (Doolittle, 1991) . In a study that followed patients for 12 months after stroke, patients described the persistence of the fear of dying that accompanied the stroke, the inescapability of the stroke's bodily effects, and recurrent thoughts of the lack of control they experienced, even months later (Burton, 2000) . Even patients with no lasting functional impairment (as is typical of TIA) have described short-term deficits as traumatic (Kiphuth, Utz, Noble, Köhrmann, & Schenk, 2014 ). This document is copyrighted by the American Psychological Association or one of its allied publishers.
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The Prevalence and Cardiovascular Consequences of PTSD-Like Reactions After CVD Events
The population burden of these acute CVD events makes clear the public health impact of the psychological disorders that accompany them and how that impact will grow as the population ages. However, PTSD researchers to date have tended to focus on clearly traumatic external events, such as combat or sexual assault, for a host of good reasons. This dearth of research in the civilian aging population means that relatively little is known about the character and consequences of PTSD due to common CVD events such as heart attack and stroke.
Briefly, the meta-analytic estimate of the prevalence of PTSD measured in the year after ACS and stroke/TIA events yields a relatively consistent picture (Edmondson et al., , 2013 . For ACS, the overall prevalence of PTSD was 12% across 24 studies (N ϭ 2,383; Edmondson et al., 2012) . In the seven studies (N ϭ 1,014 patients) that assessed the incidence of stroke-induced PTSD, 23% (95% CI [16%, 33%]) of TIAMS survivors screened positive for PTSD in the first year after stroke, and 11% (95% CI [8%, 14%]) screened positive for PTSD more than a year after stroke (Edmondson et al., 2013) . More recently, the first study to assess PTSD in a sample comprised exclusively of TIA patients found that 29% screened positive for PTSD at 3 months post-TIA (Kiphuth et al., 2014) .
For psychologists, the high prevalence of traumatic distress in these patients is enough to warrant mobilization of researchers and clinicians to address this glaring need. However, for cardiologists, neurologists, and other physicians tasked with promoting the cardiovascular health of CVD patients, psychiatric consequences of CVD events are understandably secondary concerns. That is not to say that physicians are unconcerned with psychiatric issues. Indeed, recent decades have seen an explosion of research, clinical guideline activity, and policy prescriptions to address depression in ACS and TIAMS patients (Davidson et al., 2006) . A primary reason for that activity, however, was the consistent observational finding that depression is associated with increased risk for secondary CVD events in these patients (Pan, Sun, Okereke, Rexrode, & Hu, 2011) . Unfortunately, no study to date has demonstrated that treating depression in ACS patients reduces secondary CVD risk, and to our knowledge, no such study has been conducted with TIAMS survivors (Towfighi et al., 2017) .
Few studies have assessed the association of ACS-or TIAMS-induced PTSD with secondary CVD risk, although large cohort studies are currently underway. The limited evidence collected to date suggests that PTSD due to these events increases secondary risk, with a meta-analysis of 609 ACS patients suggesting that ACS-induced PTSD doubles risk for a second ACS or mortality in studies that followed patients for 1 to 3 years (relative risk ϭ 2.0; ). An intermediate analysis of the largest study to date, which is still ongoing, is consistent with that estimate. Participants' odds of being readmitted to the hospital in the month after ACS increased by 32% per 10 points on the Acute Stress Disorder Scale .
No study to date has tested whether TIAMS-induced PTSD is associated with increased risk for recurrent TIAMS or mortality, although the similarities in pathophysiology of ACS and stroke, and hypothesized mechanisms of the association of PTSD with secondary risk, suggest that TIAMS-induced PTSD is likely to be an important intervention target. The mechanisms by which PTSD is thought to increase secondary risk after both ACS and TIAMS events include autonomic imbalance and its downstream effects (e.g., increased blood pressure, endothelial dysfunction, excess inflammation, atherosclerosis) and behavioral dysregulation (e.g., medication nonadherence, sedentary behavior, excess tobacco and alcohol use; Edmondson & von Känel, 2017) . Further, PTSD is associated with a threefold increased risk for incident stroke (Chen et al., 2015) .
To determine whether TIAMS-induced PTSD is associated with secondary CVD risk, a large cohort study (N ϭ 1,000) of PTSD in TIAMS patients is ongoing, including innovative mechanistic substudies (i.e., 24-hr ambulatory electrocardiogram with electronic momentary assessment of intrusive thoughts keyed to autonomic activity, actigraphy for physical activity, sedentary behavior, and sleep, as well as electronic assessment of medication adherence).
Is It PTSD?: Evidence for the Enduring Somatic Threat Model of PTSD Due to Life-Threatening Medical Events
The prevalence and apparent consequences of PTSD-like reactions to acute cardiovascular events make clear the importance of understanding those reactions in order to develop means for ameliorating them. The EST model was offered to outline similarities and differences between PTSD due to acute life-threatening medical events and PTSD due to more stereotypical traumatic events. The differences include (a) an external/discreet versus somatic/ ongoing triggering event, (b) a past versus present/future temporal focus of threatening cognitions/intrusions, (c) different manifestations and consequences of avoidance behavior, and (d) different character and consequences of hyperarousal. Aside from clear similarities between the two, such as the defined onset of symptoms keyed to an event and similar interrelationships among symptom clusters that appear to conform to well-defined constructs (Sumner et al., 2015) -that is, likely cycles of intrusions and avoidance, physiological hyperarousal and sleep difficulties, hypervigilance to threat cues, and negative alterations in cognition and mood-the EST model proposes an underappreciated This document is copyrighted by the American Psychological Association or one of its allied publishers.
similarity that connects affected survivors of combat and cardiac events. Both sets of psychological reactions are characterized by a new awareness and fear of mortality that causes and maintains psychological symptoms, whether the triggering event was a discrete/external or an ongoing/ somatic one.
In an initial observational test of the EST model, we tested hypotheses based on EST propositions concerning the unique ongoing/somatic source of threat, the future temporal orientation of intrusive cognitions, and the centrality of mortality fear. Specifically, we tested whether PTSD at 1-month post-ACS indeed required both high peritraumatic threat (high fear of death, perception of vulnerability, lack of control) during the ACS and ongoing present-and futureoriented cardiac threat perceptions in the subsequent month. We assessed peritraumatic threat during ED evaluation of 284 patients with a provisional ACS diagnosis. One month after participants were discharged from the hospital, we assessed their cardiac threat perceptions ("It scares me when my heart beats rapidly"; "When my chest feels tight, I get scared that I won't be able to breathe properly"; "When I notice my heart skipping a beat, I worry that there is something seriously wrong with me"; and "When I feel pain in my chest, I worry that I'm going to have a heart attack") and PTSD symptoms using the PTSD Checklist-Specific (PCL-S; Weathers, Litz, Herman, Huska, & Keane, 1994) for ACS. In a multiple regression model with adjustment for demographic and medical covariates, as well as preexisting PTSD and depression, we found that only those participants who perceived high levels of threat during the ACS and ongoing cardiac threat 1 month later screened positive for PTSD. Further, threat perceptions during ED evaluation for ACS were associated with higher 1-month PTSD symptoms only among those with high levels of ongoing cardiac threat (Meli et al., 2017) .
The persistent cardiovascular threat a patient perceives after the ACS may be the defining feature of PTSD-like symptoms after acute life-threatening medical events (Meli et al., 2017) , particularly if the triggering event itself caused the patient to fear for her life. This centrality of EST perceptions complicates our conceptualization of the psychological, physiological, and behavioral symptoms that accompany those threat perceptions. Unlike the Iraq war veteran whose symptoms are triggered by sensory reminders of an improvised explosive device (IED) detonation years before, but who is physically safe from harm in the present, the stroke survivor's intermittent atrial fibrillation reminds her of the truth that she will likely die of CVD. To extend the comparison, the stroke survivor experiences an IED detonation, then is forced to live the rest of her life with a live IED in her arteries. Whether the centrality of present-and future-focused fear of objectively verified life-threatening conditions in the body, rather than incursions of the past into the present, is a distinction without a difference with respect to labeling and diagnosis is still unclear. What is clear is that when patients perceive EST, it influences their cardiovascular and psychological recovery.
The standard of care after ACS requires that patients (a) comprehend that the ACS was an acute manifestation of a systemically compromised cardiovascular system (i.e., likely systemic atherosclerosis and other, largely irreversible risk factors for secondary CVD events), and (b) change their daily behavior to incorporate risk-reducing behaviors such as medication adherence and physical activity. However, that approach reinforces some patients' preoccupation with future CVD risk and may place those patients at greater risk for PTSD. Ironically, in communicating the chronic nature of CVD and emphasizing future risk, the standard approach may actually undermine the health-promoting behaviors it is meant to promote.
Indeed, we have found that PTSD-and specifically EST perceptions-substantially undermine health behaviors that would reduce secondary CVD risk. Patients who screen positive for PTSD due to TIAMS are three times less likely to take secondary prevention medications relative to those who report few or no PTSD symptoms (Kronish, Edmondson, Goldfinger, Fei, & Horowitz, 2012) . There is no place that a patient can go that their cardiovascular system will not follow, so avoidance symptoms tend to illustrate patients' attempts to minimize reminders of their ongoing cardiovascular risk. For example, ACS patients with high PTSD symptoms report avoiding their medications for secondary CVD risk reduction because medications serve as reminders of patients' ongoing CVD risk (Husain, Edmondson, Kautz, Umland, & Kronish, 2018) . Similarly, the physiological signals that accompany physical activity (e.g., increased heart rate, shortness of breath) serve as reminders of CVD risk in patients with ACSinduced PTSD, and patients with ACS-induced PTSD are more likely to avoid recommended physical activity for fear of a recurrent CVD event (Monane, Sanchez, Kronish, Edmondson, & Diaz, 2018) . Importantly, the association of PTSD with medication nonadherence is specific to PTSD due to the same type of medical event for which secondary prevention medications are prescribed. In a systematic review and meta-analysis of 16 articles (N ϭ 4,483 chronic disease patients), the pooled effect size of the risk of medication nonadherence associated with a positive screen for any PTSD was an odds ratio (OR) of 1.22 (95% CI [1.06, 1.41]). However, the association was significant only across the six studies of medical event-induced PTSD (OR ϭ 2.08, 95% CI [1.03, 4.18], p ϭ .04), with an effect size nearly double that found in the eight studies of patients with PTSD not induced by a medical event (OR ϭ 1.10, 95% CI [0.99, 1.24], p ϭ .09). This document is copyrighted by the American Psychological Association or one of its allied publishers.
Preliminary Implications for Clinical Practice in Medicine and Health Psychology
The ongoing cardiac threat perceptions necessary for PTSD in Meli et al. (2017) are the same physiological symptoms that accompany physical activity in Monane et al. (2018) , and are common hyperarousal symptoms seen in PTSD across trauma types. They can be viewed as interoceptive awareness of (for the most part) normal cardiovascular function (e.g., increased heart rate during physical activity) that CVD patients interpret catastrophically. Findings from our group and other researchers studying medically induced PTSD around the world suggest that the "teachable moment," which leverages or increases patients' perception of EST to motivate behavior change, may initiate or magnify a pathological hypersensitivity to normal afferent physiological signals that patients view as threat cues. This hypersensitivity, in turn, may cause patients to avoid behaviors that would reduce their risk for recurrent CVD events, seemingly because the psychological equanimity afforded in the short term by avoiding reminders of CVD risk outweighs the marginal perceived reduction in secondary risk afforded by engaging in any given instance of medication adherence or physical activity.
The Present Study
Our current understanding of PTSD due to acute CVD events is that some patients become sensitized to omnipresent physiological threat cues that they associate with present and future CVD risk, which causes a pathological somatic hyperawareness and concurrent avoidance of key secondary prevention behaviors that is negatively reinforced in a vicious cycle. When we initially proposed the EST model, we hypothesized that "ironically, it is possible that reducing patients' perceptions of EST may be a means for reducing both PTSD symptoms and improving cardiovascular prognosis" (Meli et al., 2017, pp. 7-8) . In the present study, we test whether an invasive procedure, delivered in-hospital during the index hospitalization for ACS, was associated with reduced PTSD risk in an observational cohort of patients diagnosed with NSTEMI (death of cardiac tissue) or UA (ischemia with increased cardiac demand but no tissue death).
When patients are diagnosed with some forms of ischemic heart disease, including NSTEMI and UA, they can be treated with medications alone or receive cardiac catheterization with or without revascularization (see https://www .nhlbi.nih.gov/health-topics). The exception is ST-elevation myocardial infarction (STEMI; acute cardiac tissue death, more severe than NSTEMI). STEMI and NSTEMI have similar long-term prognoses (Bode & Zirlik, 2007) , but STEMI patients have a different treatment pathway involving immediate catheterization before they can enroll in our study and before threat perceptions can be measured.
Cardiac catheterization is stressful. It is performed while the patient is awake, but it is mostly painless. It involves inserting a tube into the groin and guiding it to the occluded coronary artery to determine the extent of coronary disease. Often, during catheterization, cardiologists will perform a percutaneous coronary intervention (PCI) using coronary angioplasty (inflating a balloon to open the arterial occlusion to promote blood flow) and/or placement of a stent in the artery to reinforce the arterial wall and hold it open to allow blood to pass more easily to the heart. For more severely diseased arteries, patients may receive a coronary artery bypass graft (CABG), in which a healthy artery from elsewhere in the body is grafted onto the coronary artery, and blood flow is rerouted through the newly placed grafted section of artery-bypassing the diseased section. PCI, stent placement, and CABG are procedures to physically restore blood flow and are collectively termed revascularization.
For many NSTEMI/UA patients, there are no clear survival or quality-of-life benefits of invasive procedures such as PCI/stent placement over optimal medication therapy to promote arterial health and improve blood flow to the heart. The use of either invasive revascularization or medical therapy is guided by patient risk stratification, and current status of ischemic disease, with lower risk patients receiving medical therapy if the ischemic event stabilizes so that invasive procedures are deemed unnecessary (Amsterdam et al., 2014) . Given the clinical equipoise surrounding revascularization procedures for many NSTEMI/UA patients at low-moderate risk strata, rates of revascularization procedures for NSTEMI and UA differ substantially across hospitals and across cardiologists within hospitals.
Because the EST model posits that perception of ongoing threat in the body is the central driver of PTSD symptoms in ACS patients, we hypothesized that receiving a revascularization procedure would be associated with decreased ACSinduced PTSD symptoms at 1 month relative to receiving medical management only. Previous research has shown that ACS patients who undergo cardiac catheterization with revascularization are 4 times more likely to believe they are "cured" than patients who are medically managed (Rothberg et al., 2010; Waring et al., 2016) . Similarly, for some types of ischemic heart disease, recent sham-controlled trials suggest that patient-reported benefits of stents from prior randomized controlled trials were likely due to powerful placebo effects of invasive procedures (Al-Lamee et al., 2018) .
Although meta-analyses reveal that early invasive coronary procedures may reduce long-term cardiovascular risk and mortality in some ACS patients (Fox et al., 2010) , less is known about their impact on patients' psychological adjustment. Although catheterization and revascularization are stressful in the short term (Boyer et al., 2013; Zhang, This document is copyrighted by the American Psychological Association or one of its allied publishers.
2015), these interventions may substantially reduce psychological distress in the weeks following ACS. To test the association of ACS management strategy with subsequent psychological adjustment, we compared ACS-induced PTSD symptoms at 1-month postdischarge across patients who received coronary catheterization, revascularization, or medical management at the time of the ACS.
Method
Participants were enrolled in the Reactions to Acute Care and Hospitalization (REACH) study, an observational cohort study of PTSD and secondary cardiovascular risk in patients with suspected ACS in the ED. Participants were enrolled at Columbia/NewYork-Presbyterian Hospital in New York between November 2013 and January 2016. Inclusion criteria included English or Spanish spoken language, age 18 years or older, and presentation to the ED with NSTEMI or UA. NSTEMI is defined by a typical rise and gradual fall (troponin levels) or more rapid rise and fall (creatine kinase MB levels) of biochemical markers of infarction with one of the following in the absence of ST elevations: (a) ST-segment depression, (b) T-wave abnormalities, or (c) ischemic symptoms without ST-segment depression or T-wave abnormalities in the presence or absence of chest discomfort (unexplained nausea and vomiting or diaphoresis; persistent shortness of breath; unexplained weakness, dizziness, lightheadedness, or syncope). UA is defined by angina pectoris (or equivalent type of ischemic discomfort) with no biochemical evidence of MI and any of the following within the 6 weeks prior to admission: (a) angina occurs at rest and is prolonged, usually longer than 20 min; (b) new-onset angina of least Class II severity according to the Canadian Cardiovascular Society criteria (Campeau, 1976) ; or (c) recent worsening of angina reflected by an increase in severity of at least one class level to at least Class II according to the Canadian Cardiovascular Society criteria. Exclusion criteria included STEMI, severe psychiatric illness, and lack of availability for follow-up. Analyses were limited to participants with a discharge diagnosis of ACS confirmed by a study cardiologist and no prior history of coronary artery disease in the medical record. The study was approved by the Institutional Review Board at Columbia University Medical Center, and all participants provided written informed consent.
Participants reported on their threat perceptions (e.g., fear of imminent death, lack of control, vulnerability) during ED enrollment on a six-item ED Perceptions questionnaire, using a 5-point Likert scale ranging from 0 (not at all) to 4 (extremely; White, Edmondson, Umland, Sanchez, & Chang, 2017) . Preexisting PTSD (PTSD Checklist-Civilian, keyed to a prior traumatic event from the Life Events Checklist; PCL-C; Weathers et al., 1994) and depression symptoms (Patient Health Questionnaire [PHQ]; Kroenke et al., 2009 ) at baseline were assessed in person during inpatient stay or by phone interview or online survey for participants discharged prior to interview (Mdn ϭ 2.5 days later). ACS management strategy (i.e., medical management, cardiac catheterization without revascularization, revascularization by PCI or CABG) was assessed via chart review. A cardiologist (Marwah Abdalla) reviewed documentation of management strategies to determine whether systematic differences across patients' CVD status explained treating cardiologists' choice of management strategy. One month after discharge, ACS-induced PTSD was assessed by phone using the 17-item PCL-S with specific reference to ACS as the stressor by research coordinators who were blinded to ACS management strategy.
First, we tested the unadjusted effect of management strategy group on 1-month PTSD symptoms with one-way analysis of variance (ANOVA). Next, using multiple regression, we tested the independent effects of ED threat perceptions and management strategy group (Model 1), and their interaction (Model 2), on 1-month PTSD symptoms. Model 3 further adjusted for demographic characteristics (age, sex, race, and ethnicity), clinical covariates (Global Registry of Coronary Events [GRACE] cardiac risk score, Charlson comorbidity index, and ACS type [NSTEMI vs. UA]), as well as preexisting PTSD and depression. Further, to adjust for the potential psychological reassurance of stress test results, Model 3 also adjusted for whether an in-hospital stress test was conducted. Finally, Model 3 adjusted for ED crowding at participant admission (Emergency Department Work Index), which has been associated with 1-month ACS-induced PTSD symptoms (McCarthy et al., 2008) . Missing data (n ϭ 13, 1-month PCL-S scores; n ϭ 1, ED threat perceptions; n ϭ 7, ethnicity; n ϭ 1, GRACE score; n ϭ 11, preexisting PCL-C scores; and n ϭ 4, PHQ scores) were imputed using the multiple imputation procedure in SAS 9.4, with contribution of all model variables and additional demographic variables (first language, Englishspeaking proficiency, partner status, education, and health insurance). One participant who died prior to 1 month was excluded from analyses.
Results
Of 143 participants (see Table 1 ), 56.6% were NSTEMI patients and 43.4% were UA patients. During hospitalization, 30.1% received medical management (of whom 14.0% declined a cardiac procedure), 24.5% received catheterization only, and 45.5% received revascularization (79.7% PCI; 20.3% CABG). There was a marginally significant effect of group on mean 1-month PTSD score in the unadjusted one-way ANOVA, F(2, 140) ϭ 2.59, p ϭ .079. As hypothesized, the revascularization group had significantly lower 1-month PTSD symptoms than the medical management group (B ϭ Ϫ5.32, 95% CI [Ϫ9.77, Ϫ0.87]), This document is copyrighted by the American Psychological Association or one of its allied publishers.
This article is intended solely for the personal use of the individual user and is not to be disseminated broadly. , were significantly associated with 1-month PTSD symptoms. In Model 2, the interaction of ED threat perceptions and revascularization management strategy was statistically significant, such that participants who experienced the ACS as highly threatening during ED evaluation and were revascularized had lower PTSD symptoms at 1 month relative those who experienced the ACS as highly threatening in the ED but were medically managed (B ϭ Ϫ1.11, 95% CI [Ϫ2.11, Ϫ0.11]), t(123.36) ϭ Ϫ2.20, p ϭ .029. In the fully adjusted Model 3, the interaction of ED threat perceptions and revascularization management strategy remained significant (B ϭ Ϫ1.01, Note. Significant parameters for each model are indicated by bold font. PTSD ϭ posttraumatic stress disorder; SE ϭ standard error; ED ϭ emergency department; C ϭ catheterization-only group (relative to medical-management-only group); C/R ϭ catheterization-plus-revascularization group (relative to medical-management-only group); GRACE ϭ Global Registry of Acute Coronary Events; NSTEMI ϭ non-ST-elevation myocardial infarction (relative to unstable angina); EDWIN ϭ Emergency Department Work Index. This document is copyrighted by the American Psychological Association or one of its allied publishers.
95% CI [Ϫ2.01, Ϫ0.01]), t(114.09) ϭ Ϫ2.00, p ϭ .048 (see Figure 1 and the online supplementary materials). The predicted PTSD score for participants one standard deviation above the mean on ED fear who were medically managed (38.6) was 14 points (1 SD) higher than the predicted PTSD score in revascularized participants (24.2). One concern with respect to the finding that revascularized participants reported lower PCL-S scores at 1 month postdischarge relative to medically managed participants is that six of the medically managed group were determined to have received medical management because they declined a revascularization procedure that was considered appropriate at least. Because those six participants may have differed from the rest of the sample in a way that may have influenced our findings, we conducted a sensitivity analysis with data from those participants removed. Results were unchanged. Indeed, the parallel effect for the interaction term in Model 3 may have been slightly stronger when we included only participants who did not refuse catheterization or revascularization (B ϭ Ϫ1.11, 95% CI [Ϫ2.14, Ϫ0.08]), t(100.67) ϭ Ϫ2.14, p ϭ .034.
Discussion
We found that patients who were revascularized during hospitalization for their first ACS subsequently developed lower ACS-induced PTSD symptoms than those who were managed medically, even though they had nonsignificantly higher cardiac risk as measured by the GRACE score. Further, patients' threat perceptions during ED evaluation were strongly associated with higher 1-month PTSD symptoms in patients who received no intervention, but for patients who were revascularized, 1-month PTSD symptoms were low regardless of their initial threat perceptions.
The magnitude of the revascularization effect is illustrated by a comparison of predicted 1-month PTSD scores for two patients who were highly distressed during ACS evaluation (ED threat scores 1 SD greater than the sample mean) and differed primarily on the management strategy they received. The medically managed patient would score above the screening cutoff for PTSD diagnosis (i.e., Ն33; see the portion of Figure 1 to the right of the vertical gray line), whereas the revascularized patient would score 14 points lower (corresponding to ϳ1 SD on the PCL-S), suggesting little impact of the ACS on psychological wellbeing (National Center for PTSD, 2014). This difference is large but consistent with the EST model of ACS-induced PTSD, which suggests that no matter how acutely threatening the index ACS event, patients who believe that the cause of the ACS has been "cured" (Rothberg et al., 2010; Waring et al., 2016) may have lower risk for subsequent PTSD. Relationship between ED threat perceptions and 1-month PTSD symptoms by group. The model controls for age, gender, ethnicity, GRACE risk score, Charlson comorbidity score, baseline PTSD symptoms, depressive symptoms, ACS type (unstable angina or non-ST elevation myocardial infarction), EDWIN score, and the administration of a stress test. Regression lines are plotted for the three groups: medical management only (solid), catheterization only (dotted), and revascularization (dashed). The vertical gray line marks M ϩ 1 SD in threat perceptions, above which group differences in PTSD symptoms were most pronounced (see Results section). ED ϭ emergency department; PTSD ϭ posttraumatic stress disorder; GRACE ϭ Global Registry of Acute Coronary Events; ACS ϭ acute coronary syndrome; EDWIN ϭ Emergency Department Work Index. This document is copyrighted by the American Psychological Association or one of its allied publishers.
Consistent with this interpretation, PTSD symptoms were lowest in participants who were revascularized and highest in those who were medically managed, but participants who were catheterized but not revascularized had PTSD scores between the other two groups. Similarly, completing a cardiac stress test in-hospital was not significantly associated with 1-month PTSD symptoms. We interpret these findings as suggestive of a threshold effect for an intervention to provide psychological security. Similar to the recent findings suggestive of a strong placebo effect of sham revascularization in the ORBITA trial in stable CHD patients (AlLamee et al., 2018) , the intuitive secondary risk reduction provided by an invasive revascularization procedure may be particularly powerful for allowing patients to leave the hospital feeling "cured."
Although this study is limited by its relatively small sample size, single-site recruitment, and lack of randomization to management strategy, it is the first study to assess the association of different in-hospital acute medical treatments with subsequent PTSD symptoms. Randomization would almost certainly be unethical, and the study design allowed for assessment of threat perceptions during the ACS event, which is rare, and adjustment for the most powerful known contributors to ACS-induced PTSD risk (Ozer, Best, Lipsey, & Weiss, 2003) . These strengths, as well as our decision to limit the analysis to patients with no prior coronary artery disease history, increase our confidence that the observed association of revascularization with PTSD was not confounded by patient, hospital, or treatment variables.
Nevertheless, there are several limitations to this study. First, the mechanisms by which catheterization and revascularization procedures may influence PTSD outcomes remain untested for the sample in the present analysis. Despite this shortcoming, there is reason to believe that EST may indeed be at least partly responsible for the observed effects, especially because perceived threat at baseline was implicated in the apparently beneficial outcomes associated with revascularization. Future research should include measures of subjective threat and safety as well as explicit questions about perceptions of being cured to replicate and extend previous literature. A second limitation was the relatively small sample size. Nevertheless, the smallest subsample (n ϭ 35) was the catheterization-only group, but the critical finding regarding the interaction with threat perceptions involved the larger catheterization-and-revascularization (n ϭ 65) and medical-management-only (n ϭ 43) groups.
A third limitation is related to the necessary design restriction that the patients could not be randomly assigned to intervention groups. The medical-management patients may have differed from patients who received catheterization and/or revascularization with respect to aspects of treatment that may not have been fully accounted for in the adjusted models. For example, a cardiac stress test was administered more often to medical management than the other two groups (which we accounted for), and other such experiences might not have been captured. Critically, however, the different management groups did not differ significantly in cardiac risk or medical comorbidity severity, as indicated by the GRACE risk score and Charlson comorbidity index (see Table 1 ).
Electronic record review revealed that many patients in the medical-management group were later deemed low risk for ACS: Most (86.0%) received no catheterization because medical management was deemed appropriate, whereas catheterization and revascularization were obviously deemed appropriate for the other groups. Some participants refused catheterization/revascularization (14.0%), and so were included in the medical management group even though an intervention may have been indicated. The sensitivity analysis with refusers excluded yielded nearly identical findings as the primary analysis. Whether or not revascularization, catheterization, or medical management groups differed with respect to ACS severity, though, PTSD symptoms were substantially higher in the medical management group. There was no evidence that the groups differed significantly on cardiovascular severity (e.g., GRACE risk score), and the medical management group was deemed lowest risk of all three groups.
Prior research has shown that the objective severity of cardiac events is unrelated to subsequent PTSD , but if differential severity affected results, we would expect those with less serious events to have lower PTSD if all else were equal. We interpret the finding that medically managed patients had lower PTSD symptoms as further support for the hypothesized effect of management strategy on participants' EST perception. This interpretation is further strengthened by the interaction of patients' ED threat perceptions with CVD management strategy on subsequent PTSD symptoms, as revascularization appeared to decouple the strong association of threat perceptions during evaluation for ACS in the ED with subsequent PTSD.
Implications for Practice
The importance of preventing or treating CVD-induced PTSD (or PTSD-like reactions) is becoming increasingly clear (Vilchinsky, Ginzburg, Fait, & Foa, 2017) . ACSinduced PTSD is associated with increased risk for ACS recurrence and mortality over 1 to 3 years . Thus, the observed reduction in PTSD symptoms associated with revascularization may be a component of the prognostic benefit of PCI or CABG.
Critically, revascularization interventions may influence the autonomic and behavioral pathways (Hassan Abdelnabi, Zaki, Sadaka, & Nawar, 2018; Hickson et al., 2017 ) that have been proposed as relevant to the secondary health risks of ACS-induced PTSD (Edmondson & von Känel, 2017) . In This document is copyrighted by the American Psychological Association or one of its allied publishers.
the days and months following the revascularization procedures, patients demonstrate increased high-frequency heart rate variability (Hassan Abdelnabi et al., 2018) , a measure of parasympathetic nervous system activity associated with improved autonomic balance that has been shown to be impaired in PTSD (Nagpal, Gleichauf, & Ginsberg, 2013) . Furthermore, revascularization interventions are associated with increased medication adherence to statins in cardiac patients (Hickson et al., 2017) . These previous findings are consistent with the present results indicating that revascularization may be associated with a reduction in PTSD symptoms. Although cardiovascular intervention decisions should not be determined by psychological outcomes, physicians and surgeons should be aware that interventions may have a strong psychological impact. Further, when naturally occurring psychological benefits of a procedure are identified, behavioral medicine researchers can use those findings to develop psychological interventions that target similar psychological mechanisms. Future studies should confirm the present finding and determine whether the lower PTSD symptom score in revascularized patients is due to a reduction in those patients' perceptions of ongoing cardiac risk and whether the psychological benefits persist in subsequent months independently from improvements in ACS symptoms.
There are important implications for clinical practice if our findings are confirmed and if future research shows that ongoing cardiac risk perceptions indeed underlie the association between revascularizations and subsequent PTSD symptoms. Physicians may consider educating their patients more thoroughly about the substantial benefits of pharmacology for reducing secondary risk without invasive intervention. This knowledge may help offset medically managed patients' concerns that they remain un-"cured" by increasing the perceived benefits of noninvasive treatments. Researchers should determine whether educational interventions that accurately represent secondary risk may reduce PTSD in medically managed patients. Finally, researchers should test whether cardiac risk perceptions can serve as a modifiable, intermediate target for psychological interventions aimed at preventing or treating PTSD after ACS.
Implications for Theory and Intervention Development
These results add to a growing literature on PTSD in medical settings, which includes an excellent recent review by Vilchinsky et al. (2017) and a recent special issue of General Hospital Psychiatry (July-August 2018; Vol. 53), both of which broaden and deepen the field of inquiry. The most important contribution of the present finding is that it suggests the possibility that risk for PTSD after lifethreatening medical events may be reduced substantially by in-hospital interventions. Although we are not advocating that coronary artery stents be considered a prophylactic therapy for ACS-induced PTSD, even if future research replicates the finding, we see this finding as an important clue concerning mechanisms that may be targeted by psychological treatments to reduce PTSD risk-and a first hint at an effect size that may be reached with a well-designed intervention.
Viewed in light of previous studies that suggest a potential placebo effect of sham stent placement, and that patients are four times more likely to report being cured of heart disease after coronary interventions relative to medical management, this study highlights that there may be a need for psychological interventions to reduce patients' ongoing sense that their cardiovascular system is a constant threat to their lives. It may be that providing such interventions in-hospital could reduce risk for the development of PTSD symptoms by intervening before such symptoms sensitize patients to afferent physiological cues and before patients develop an automatic cognitive interpretation of those cues as threatening.
One prior study attempted an intervention to prevent PTSD in ACS patients, the MI-SPRINT trial, but low PTSD rates in both the intervention and control groups likely limited the study's power to detect any effect of the psychoeducation intervention offered (von Känel et al., 2018) . Even so, the present results provide preliminary evidence for a slightly different approach to preventing the development of PTSD-like reactions after acute CVD events. Rather than addressing awareness of psychological reactions, we propose that it may be fruitful to target EST perception, perhaps through in-hospital exposure to physiological cues paired with physician-affirmed safety signals.
Finally, although our focus has been on the association of different treatments with subsequent PTSD symptoms, it is important to note the statistical moderation of the association of ED threat perceptions with subsequent PTSD by CVD management strategy. That finding points to other important areas for future research, including identifying individual differences in cognitive and emotional responses to acute life-threatening medical events and tailoring interventions to reduce long-term negative sequelae of such responses. For example, recent research on neurological structure and function suggest that external and interoceptive threats are processed by distinct but related neural structures/circuits , that exposure therapy for PTSD can alter functional connectivity of neural structures to support adaptive threat processing (Zhu et al., 2017) , and that the short and disrupted sleep common to hospital stays can weaken functional connectivity of the same structures (Shao et al., 2014) .
In summary, this work represents part of a new development in psychocardiology, a field with a rich history of This document is copyrighted by the American Psychological Association or one of its allied publishers.
groundbreaking interdisciplinary science. The application of research in trauma, PTSD, and experimental existential psychology to cardiology is relatively new, but it is beginning to yield fruit. The population we study is growing, the work is important, and the tools are improving rapidly (Khalsa & Lapidus, 2016) . The present study is one of a growing number of recent studies that lay the foundation for new hospital guidelines that address patients' threat perceptions, and for future interventions that health psychologists and other clinicians may develop with the goal of helping the millions of patients who experience acute lifethreatening cardiovascular events each year to live at peace with their bodies.
